FINAL Press Release Biocon Reports a Strong Q1FY17 Revenues at Rs 952 Crore, up by 11 %; EBITDA Up 15% to Rs 271 Crore

Source URL: www.biocon.com

• Recombinant proteins
• Peptide hormones
• Generally Accepted Accounting Principles
• Biotechnology
• Eli Lilly and Company
• Insulin analog
• Biosimilar
• Biocon
• Trastuzumab
• Pharmaceutical industry in India
• Kiran Mazumdar-Shaw
• Biopharmaceutical

Investor Presentation June 2016 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS │ BLOOMBERG: BIOS IN │ WWW.BIOCON.COM

Source URL: www.biocon.com

• Peptide hormones
• Recombinant proteins
• Specialty drugs
• Biotechnology
• Monoclonal antibodies
• Trastuzumab
• Biocon
• Insulin glargine
• Insulin
• Biosimilar
• Pharmaceutical industry in India
• Biopharmaceutical

PDF Document

Source URL: www.biocon.com

Biological Conservation–31 www.elsevier.com/locate/biocon Modelling butterfly species richness using mesoscale environmental variables: model construction and validation for mountain ranges in the Great

Source URL: www.ag.unr.edu

• Regression analysis
• Econometrics
• Linear regression
• Predictive modelling
• Poisson regression
• Species richness
• Toquima Range
• Species distribution
• Coefficient of determination
• Economic model
• Statistics

Biological Conservationwww.elsevier.com/locate/biocon Corrigendum

Source URL: www.francoandreone.it

PDF Document

Source URL: www.biocon.com

PDF Document

Source URL: www.biocon.com

Press Release Biocon Q4FY16 Net Profit at Rs 361 Cr Revenue Crosses Rs 1,000 Cr; Up 17% FY 16 Revenues up 14% at Rs 3,570 Cr Net Profit at Rs 896 Cr

Source URL: www.biocon.com

PDF Document

Source URL: www.biocon.com

BIOLOGICAL CONSERVATION Biological Conservation–401 www.elsevier.com/locate/biocon

Source URL: www.stat.ualberta.ca